BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36756127)

  • 1. Transcription factor TFII-I fine tunes innate properties of B lymphocytes.
    Singh A; Kaileh M; De S; Mazan-Mamczarz K; Bayarsaihan D; Sen R; Roy AL
    Front Immunol; 2023; 14():1067459. PubMed ID: 36756127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sjögren's syndrome-associated SNPs increase GTF2I expression in salivary gland cells to enhance inflammation development.
    Shimoyama S; Nakagawa I; Jiang JJ; Matsumoto I; Chiorini JA; Hasegawa Y; Ohara O; Hasebe R; Ota M; Uchida M; Kamimura D; Hojyo S; Tanaka Y; Atsumi T; Murakami M
    Int Immunol; 2021 Jul; 33(8):423-434. PubMed ID: 34036345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a mouse model for a conditional inactivation of Gtf2i allele.
    Enkhmandakh B; Stoddard C; Mack K; He W; Kaback D; Yee SP; Bayarsaihan D
    Genesis; 2016 Jul; 54(7):407-12. PubMed ID: 27194223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity and complexity in chromatin recognition by TFII-I transcription factors in pluripotent embryonic stem cells and embryonic tissues.
    Makeyev AV; Enkhmandakh B; Hong SH; Joshi P; Shin DG; Bayarsaihan D
    PLoS One; 2012; 7(9):e44443. PubMed ID: 22970219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of Gtf2i-β/δ transcription factors to the ARMS2 gene leads to increased circulating HTRA1 in AMD patients and in vitro.
    Pan Y; Iejima D; Nakayama M; Suga A; Noda T; Kaur I; Das T; Chakrabarti S; Guymer RH; DeAngelis MM; Yamamoto M; Baird PN; Iwata T
    J Biol Chem; 2021; 296():100456. PubMed ID: 33636181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23.
    Li Y; Zhang K; Chen H; Sun F; Xu J; Wu Z; Li P; Zhang L; Du Y; Luan H; Li X; Wu L; Li H; Wu H; Li X; Li X; Zhang X; Gong L; Dai L; Sun L; Zuo X; Xu J; Gong H; Li Z; Tong S; Wu M; Li X; Xiao W; Wang G; Zhu P; Shen M; Liu S; Zhao D; Liu W; Wang Y; Huang C; Jiang Q; Liu G; Liu B; Hu S; Zhang W; Zhang Z; You X; Li M; Hao W; Zhao C; Leng X; Bi L; Wang Y; Zhang F; Shi Q; Qi W; Zhang X; Jia Y; Su J; Li Q; Hou Y; Wu Q; Xu D; Zheng W; Zhang M; Wang Q; Fei Y; Zhang X; Li J; Jiang Y; Tian X; Zhao L; Wang L; Zhou B; Li Y; Zhao Y; Zeng X; Ott J; Wang J; Zhang F
    Nat Genet; 2013 Nov; 45(11):1361-5. PubMed ID: 24097066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymic epithelial tumors: examining the GTF2I mutation and developing a novel prognostic signature with LncRNA pairs to predict tumor recurrence.
    Liu W; Yang HS; Zheng SY; Weng JH; Luo HH; Lei YY; Feng YF
    BMC Genomics; 2022 Sep; 23(1):656. PubMed ID: 36114454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of GTF2I promotes neuronal apoptosis and synaptic reduction in human cellular models of neurodevelopment.
    Adams JW; Vinokur A; de Souza JS; Austria C; Guerra BS; Herai RH; Wahlin KJ; Muotri AR
    Cell Rep; 2024 Mar; 43(3):113867. PubMed ID: 38416640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal deletion of Gtf2i results in developmental microglial alterations in a mouse model related to Williams syndrome.
    Bar E; Fischer I; Rokach M; Elad-Sfadia G; Shirenova S; Ophir O; Trangle SS; Okun E; Barak B
    Glia; 2024 Jun; 72(6):1117-1135. PubMed ID: 38450767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GTF2I rs117026326 polymorphism is associated with anti-SSA-positive primary Sjögren's syndrome.
    Zheng J; Huang R; Huang Q; Deng F; Chen Y; Yin J; Chen J; Wang Y; Shi G; Gao X; Liu Z; Petersen F; Yu X
    Rheumatology (Oxford); 2015 Mar; 54(3):562-4. PubMed ID: 25480810
    [No Abstract]   [Full Text] [Related]  

  • 11. Essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.
    Enkhmandakh B; Makeyev AV; Erdenechimeg L; Ruddle FH; Chimge NO; Tussie-Luna MI; Roy AL; Bayarsaihan D
    Proc Natl Acad Sci U S A; 2009 Jan; 106(1):181-6. PubMed ID: 19109438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of TFII-I: Old Guard Wearing New Hats.
    Roy AL
    Trends Mol Med; 2017 Jun; 23(6):501-511. PubMed ID: 28461154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of Williams-Beuren syndrome: TFII-I regulated targets involved in craniofacial development.
    Makeyev AV; Bayarsaihan D
    Cleft Palate Craniofac J; 2011 Jan; 48(1):109-16. PubMed ID: 20500075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interrelationship between TFII-I and E2F transcription factors at specific cell cycle gene loci.
    Shen Y; Nar R; Fan AX; Aryan M; Hossain MA; Gurumurthy A; Wassel PC; Tang M; Lu J; Strouboulis J; Bungert J
    J Cell Biochem; 2018 Jan; 119(1):712-722. PubMed ID: 28657656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ChIP-seq analysis found IL21R, a target gene of GTF2I-the susceptibility gene for primary biliary cholangitis in Chinese Han.
    Wu Z; Li H; Xu H; Feng F; Zhang F; Zhang S; Wang L; Li Y
    Hepatol Int; 2024 Apr; 18(2):509-516. PubMed ID: 37713154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the multifunctional transcription factor TFII-I in DNA damage repair.
    Roy AL
    DNA Repair (Amst); 2021 Oct; 106():103175. PubMed ID: 34280590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential role of the N-terminal region of TFII-I in viability and behavior.
    Lucena J; Pezzi S; Aso E; Valero MC; Carreiro C; Dubus P; Sampaio A; Segura M; Barthelemy I; Zindel MY; Sousa N; Barbero JL; Maldonado R; Pérez-Jurado LA; Campuzano V
    BMC Med Genet; 2010 Apr; 11():61. PubMed ID: 20403157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution structure of the general transcription factor 2I domain in mouse TFII-I protein.
    Doi-Katayama Y; Hayashi F; Inoue M; Yabuki T; Aoki M; Seki E; Matsuda T; Kigawa T; Yoshida M; Shirouzu M; Terada T; Hayashizaki Y; Yokoyama S; Hirota H
    Protein Sci; 2007 Aug; 16(8):1788-92. PubMed ID: 17600150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive and negative regulation of the transforming growth factor beta/activin target gene goosecoid by the TFII-I family of transcription factors.
    Ku M; Sokol SY; Wu J; Tussie-Luna MI; Roy AL; Hata A
    Mol Cell Biol; 2005 Aug; 25(16):7144-57. PubMed ID: 16055724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TFII-I regulates target genes in the PI-3K and TGF-β signaling pathways through a novel DNA binding motif.
    Segura-Puimedon M; Borralleras C; Pérez-Jurado LA; Campuzano V
    Gene; 2013 Sep; 527(2):529-36. PubMed ID: 23831514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.